NORGES BANK - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORGES BANK ownership history of PULMONX CORP
ValueSharesWeighting
Q4 2022$3,153,663
-16.3%
374,100
+65.5%
0.00%0.0%
Q3 2022$3,766,826
+9.8%
226,100
-3.0%
0.00%0.0%
Q2 2022$3,431,232
+161.7%
233,100
+470.2%
0.00%
Q4 2021$1,311,000
-10.9%
40,8800.0%0.00%
Q3 2021$1,471,000
+15.7%
40,880
+41.9%
0.00%
Q2 2021$1,271,00028,8000.00%
Other shareholders
PULMONX CORP shareholders Q1 2022
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 815,019$37,279,00040.66%
Yu Fan 303,030$13,861,00036.18%
ABG Innovation Capital Partners III GP Ltd 833,333$38,117,00018.73%
KPCB XIII Associates, LLC 994,971$45,510,0009.36%
Iron Triangle Partners LP 600,000$27,444,0003.49%
Miura Global Management 405,000$18,525,0003.31%
GREAT POINT PARTNERS LLC 114,345$5,230,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 937,032$42,860,0000.90%
ADAMS STREET PARTNERS LLC 114,661$5,245,0000.84%
RTW INVESTMENTS, LP 1,129,600$51,668,0000.81%
View complete list of PULMONX CORP shareholders